We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.08B
AUM Growth
+$155M
Cap. Flow
+$19M
Cap. Flow %
0.92%
Top 10 Hldgs %
39.77%
Holding
295
New
27
Increased
139
Reduced
81
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 10.19%
2 Healthcare 7.55%
3 Industrials 5.18%
4 Financials 5.12%
5 Communication Services 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIN icon
201
Fortune Brands Innovations
FBIN
$5.88B
$421K 0.02%
5,144
BSX icon
202
Boston Scientific
BSX
$69.5B
$420K 0.02%
10,860
-495
-4% -$18.7K
MO icon
203
Altria Group
MO
$114B
$411K 0.02%
8,039
+964
+14% +$43.2K
BND icon
204
Vanguard Total Bond Market
BND
$157B
$409K 0.02%
4,822
+363
+8% +$31.3K
IHF icon
205
iShares US Healthcare Providers ETF
IHF
$1.21B
$405K 0.02%
8,050
MUSA icon
206
Murphy USA
MUSA
$11.2B
$401K 0.02%
2,774
PTON icon
207
Peloton Interactive
PTON
$2.77B
$394K 0.02%
3,507
-1,558
-31% -$207K
PM icon
208
Philip Morris
PM
$297B
$393K 0.02%
4,430
-47
-1% -$3.99K
LNC icon
209
Lincoln National
LNC
$8.73B
$388K 0.02%
6,228
SCZ icon
210
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$376K 0.02%
+5,230
New +$371K
MCHP icon
211
Microchip Technology
MCHP
$40.3B
$373K 0.02%
+4,800
New +$358K
AMP icon
212
Ameriprise Financial
AMP
$48.3B
$371K 0.02%
+1,598
New +$346K
IBB icon
213
iShares Biotechnology ETF
IBB
$9.34B
$370K 0.02%
2,460
-83
-3% -$13.2K
MRNS
214
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$369K 0.02%
23,825
+11,575
+94% +$167K
ED icon
215
Consolidated Edison
ED
$40.1B
$360K 0.02%
+4,807
New +$338K
XLU icon
216
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$360K 0.02%
+11,252
New +$349K
GPC icon
217
Genuine Parts
GPC
$17.1B
$357K 0.02%
3,084
PYPL icon
218
PayPal
PYPL
$48.9B
$357K 0.02%
1,471
-324
-18% -$81.8K
BDX icon
219
Becton Dickinson
BDX
$45.6B
$343K 0.02%
1,446
-182
-11% -$44.5K
GWX icon
220
State Street SPDR S&P International Small Cap ETF
GWX
$856M
$341K 0.02%
9,116
-1,940
-18% -$71.3K
AZN icon
221
AstraZeneca
AZN
$263B
$340K 0.02%
3,420
+510
+18% +$51.3K
ARKK icon
222
ARK Innovation ETF
ARKK
$5.64B
$336K 0.02%
2,803
+58
+2% +$7.85K
AFL icon
223
Aflac
AFL
$64.9B
$334K 0.02%
6,517
+959
+17% +$46K
MU icon
224
Micron Technology
MU
$930B
$328K 0.02%
3,721
+386
+12% +$32.7K
TRV icon
225
Travelers Companies
TRV
$78.1B
$315K 0.02%
2,097

Similar funds

Grimes & Company's Q1 2021 Portfolio in Review

As of Q1 2021, Grimes & Company held 295 positions worth $2.08B, up 8% from $1.92B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grimes & Company's Q1 2021 filing shows 27 new, 139 increased, 81 reduced and 16 closed positions. Its largest new stake was Revvity: 101,873 shares worth $13.1M. The largest sale was iShares National Muni Bond ETF, an estimated $54.6M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Healthcare and Industrials.

  • Grimes & Company's largest Q1 2021 buy was Revvity: 101,873 shares worth $13.1M.
  • Grimes & Company added most to Costco in Q1 2021, an estimated $13.3M increase.
  • Grimes & Company's biggest Q1 2021 reduction was Warner Bros, cutting an estimated $18.3M.
  • Grimes & Company fully exited iShares National Muni Bond ETF in Q1 2021, selling an estimated $54.6M.
  • Grimes & Company's ten largest holdings make up 40% of its $2.08B portfolio in Q1 2021.
  • Grimes & Company opened 27 new positions and closed 16 in Q1 2021.
  • Grimes & Company's portfolio value rose 8% quarter-over-quarter to $2.08B.

Based on Grimes & Company's 13F filing for Q1 2021, filed 12 May 2021.